Inst Diagnosti Stock Fundamentals

INDISA Stock  CLP 1,591  4.40  0.28%   
Inst Diagnosti fundamentals help investors to digest information that contributes to Inst Diagnosti's financial success or failures. It also enables traders to predict the movement of Inst Stock. The fundamental analysis module provides a way to measure Inst Diagnosti's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Inst Diagnosti stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Inst Diagnosti Company Profit Margin Analysis

Inst Diagnosti's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Profit Margin

 = 

Net Income

Revenue

X

100

More About Profit Margin | All Equity Analysis

Current Inst Diagnosti Profit Margin

    
  0.1 %  
Most of Inst Diagnosti's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Inst Diagnosti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition

Based on the latest financial disclosure, Inst Diagnosti has a Profit Margin of 0.0983%. This is 100.88% lower than that of the Healthcare sector and 101.92% lower than that of the Medical Care industry. The profit margin for all Chile stocks is 107.74% lower than that of the firm.

Inst Diagnosti Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Inst Diagnosti's current stock value. Our valuation model uses many indicators to compare Inst Diagnosti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Inst Diagnosti competition to find correlations between indicators driving Inst Diagnosti's intrinsic value. More Info.
Inst Diagnosti is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about  0.25  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Inst Diagnosti is roughly  3.98 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Inst Diagnosti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Inst Diagnosti's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Inst Profit Margin Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Inst Diagnosti's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Inst Diagnosti could also be used in its relative valuation, which is a method of valuing Inst Diagnosti by comparing valuation metrics of similar companies.
Inst Diagnosti is currently under evaluation in profit margin category among its peers.

Inst Fundamentals

About Inst Diagnosti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Inst Diagnosti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Inst Diagnosti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Inst Diagnosti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Instituto de Diagnstico S.A. provides healthcare services in various medical specialties and sub-specialties in Chile. The company was founded in 1961 and is based in Providencia, Chile. INST DIAGNOSTICO is traded on Commodity Exchange in Exotistan.

Pair Trading with Inst Diagnosti

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inst Diagnosti position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inst Diagnosti will appreciate offsetting losses from the drop in the long position's value.

Moving together with Inst Stock

  0.67AAISA Administradora AmericanaPairCorr
  0.61AFPCAPITAL AFP Capital SAPairCorr

Moving against Inst Stock

  0.59CAP CAP SAPairCorr
The ability to find closely correlated positions to Inst Diagnosti could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inst Diagnosti when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inst Diagnosti - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inst Diagnosti to buy it.
The correlation of Inst Diagnosti is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inst Diagnosti moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inst Diagnosti moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inst Diagnosti can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Inst Stock

Inst Diagnosti financial ratios help investors to determine whether Inst Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Inst with respect to the benefits of owning Inst Diagnosti security.